Maria Martina Sfriso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Martina Sfriso has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Veronica Macchi
Department of Neurosciences, Institute of Human Anatomy University of Padova Padova Italy
4 shared publications Andrea Porzionato
Department of Molecular Medicine, University of Padova, Padova, Italy
2 shared publications- Camillo Di Giulio
“G. D’Annunzio” University
2 shared publications Raffaele De Caro
Department of Molecular Medicine, University of Padova, Padova, Italy
2 shared publications- Raffaele De Caro
Department of Neurosciences, Institute of Human Anatomy University of Padova Padova Italy
2 shared publications - Vincenzo Vindigni
Department of Neurosciences, Clinic of Plastic Reconstructive and Aesthetic Surgery, Padua University Hospital, 35128 Padua, Italy
2 shared publications
Latest Publications
- 1 April 2015
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 209, 106-114
Effects of hyperoxic exposure on signal transduction pathways in the lung
- 1 April 2015
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 209, 106-114
Effects of hyperoxic exposure on signal transduction pathways in the lung
- Open Access
- 26 November 2014
- Published by IntechOpen
Bioengineering of Vascular Conduits
Bioengineering of Vascular Conduits | InTechOpen, Published on: 2014-11-26. Authors: A. Pontini, M.M. Sfriso, M.I. Buompensiere, et
- 26 November 2014
- Published by IntechOpen
Open AccessBioengineering of Vascular Conduits
Bioengineering of Vascular Conduits | InTechOpen, Published on: 2014-11-26. Authors: A. Pontini, M.M. Sfriso, M.I. Buompensiere, et
- 1 October 2014
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 42 (10) , 1617-1626
Differential Effect of Liver Cirrhosis on the Pregnane X Receptor–Mediated Induction of CYP3A1 and 3A2 in the Rat
Conflicting results have been obtained by clinical studies investigating the effect of liver cirrhosis on enzyme induction. Because ethical concerns do not give consent for methodologically rigorous studies in humans, we addressed this question by examining the effect of the prototypical inducer dexamethasone (DEX) on the pregnane X receptor (PXR)–mediated induction of CYP3A1 and 3A2 in a validated animal model of liver cirrhosis obtained by exposure of rats to carbon tetrachloride. For this purpose, we assessed mRNA levels, protein expressions, and enzymatic activities of both CYP3A enzymes, as well as mRNA and protein expressions of PXR in rat populations rigorously stratified according to the severity of liver insufficiency. Constitutive mRNA and protein expressions of CYP3A1 and CYP3A2 and their basal enzyme activities were not affected by liver dysfunction. DEX treatment markedly increased steady-state mRNA level, protein content, and enzymatic activity of CYP3A1 in healthy and cirrhotic rats, irrespective of the degree of liver dysfunction. On the contrary, the inducing effect of DEX on gene and protein expressions and enzyme activity of CYP3A2 was preserved in moderate liver insufficiency, whereas it was greatly curtailed when liver insufficiency became severe. mRNA and protein expressions of PXR were neither reduced by liver dysfunction nor increased by DEX treatment. These results indicate that even the inducibility of cytochrome P450 isoforms under the transcriptional control of the same nuclear receptor may be differentially affected by cirrhosis and may partly explain why conflicting results were obtained by human studies.
- 1 October 2014
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 42 (10) , 1617-1626
Differential Effect of Liver Cirrhosis on the Pregnane X Receptor–Mediated Induction of CYP3A1 and 3A2 in the Rat
Conflicting results have been obtained by clinical studies investigating the effect of liver cirrhosis on enzyme induction. Because ethical concerns do not give consent for methodologically rigorous studies in humans, we addressed this question by examining the effect of the prototypical inducer dexamethasone (DEX) on the pregnane X receptor (PXR)–mediated induction of CYP3A1 and 3A2 in a validated animal model of liver cirrhosis obtained by exposure of rats to carbon tetrachloride. For this purpose, we assessed mRNA levels, protein expressions, and enzymatic activities of both CYP3A enzymes, as well as mRNA and protein expressions of PXR in rat populations rigorously stratified according to the severity of liver insufficiency. Constitutive mRNA and protein expressions of CYP3A1 and CYP3A2 and their basal enzyme activities were not affected by liver dysfunction. DEX treatment markedly increased steady-state mRNA level, protein content, and enzymatic activity of CYP3A1 in healthy and cirrhotic rats, irrespective of the degree of liver dysfunction. On the contrary, the inducing effect of DEX on gene and protein expressions and enzyme activity of CYP3A2 was preserved in moderate liver insufficiency, whereas it was greatly curtailed when liver insufficiency became severe. mRNA and protein expressions of PXR were neither reduced by liver dysfunction nor increased by DEX treatment. These results indicate that even the inducibility of cytochrome P450 isoforms under the transcriptional control of the same nuclear receptor may be differentially affected by cirrhosis and may partly explain why conflicting results were obtained by human studies.
- Open Access
- 14 January 2013
- Published by PAGEPress Publications in European Journal of Histochemistry
- Vol. 57 (1) , e4
Decellularized omentum as novel biologic scaffold for reconstructive surgery and regenerative medicine
Decellularized omentum as novel biologic scaffold for reconstructive surgery and regenerative medicine
- 14 January 2013
- Published by PAGEPress Publications in European Journal of Histochemistry
- Vol. 57 (1) , e4
Open AccessDecellularized omentum as novel biologic scaffold for reconstructive surgery and regenerative medicine
Decellularized omentum as novel biologic scaffold for reconstructive surgery and regenerative medicine
- 1 January 2013
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 185 (1) , 9-19
Structural and neurochemical changes in the maturation of the carotid body
- 1 January 2013
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 185 (1) , 9-19
Structural and neurochemical changes in the maturation of the carotid body
- 8 August 2012
- Published by Springer Nature
- Vol. 758, 207-213
Spexin Is Expressed in the Carotid Body and Is Upregulated by Postnatal Hyperoxia Exposure
Spexin is a recently identified peptide which is expressed in many different endocrine and nervous tissues. Due to the absence of data regarding spexin expression in the carotid body, the first aim of the present study was to investigate, through immunohistochemistry and Real-Time PCR, the expression and distribution of spexin in the rat and human carotid body. Moreover, the carotid body is known to undergo various structural and functional modifications in response to hyperoxic stimuli during the first postnatal period. Thus, we also evaluated if hyperoxia during the first postnatal weeks may produce changes in the spexin expression. Materials consisted of carotid bodies obtained at autopsy from five human adult subjects and sampled from 10 six-weeks old Sprague–Dawley rats. Five rats were maintained in normoxia for the first six postnatal weeks; five rats were exposed to 60% hyperoxia for 2 weeks and then maintained in normoxia for other 4 weeks. Diffuse anti-spexin immunoreactivity was found in type I cells of both humans and rats. No spexin immunoreactivity was visible in the type II cells. Hyperoxia exposure during the first 2 weeks of postnatal life caused a reduction of volume in the carotid body still apparent after 4 weeks of normoxia. Using real-time PCR, spexin expression was 6–7 times higher in hyperoxia-exposed rats than in normoxia-exposed ones. The expression of spexin in type I cells suggests a possible modulator role in peripheral chemoreception. Moreover, the ascertained role of spexin in the regulation of cell proliferation in other tissues (e.g., adrenal gland cortex) suggests a possible role of spexin also in the hyperoxia-induced plasticity of the carotid body.
- 8 August 2012
- Published by Springer Nature
- Vol. 758, 207-213
Spexin Is Expressed in the Carotid Body and Is Upregulated by Postnatal Hyperoxia Exposure
Spexin is a recently identified peptide which is expressed in many different endocrine and nervous tissues. Due to the absence of data regarding spexin expression in the carotid body, the first aim of the present study was to investigate, through immunohistochemistry and Real-Time PCR, the expression and distribution of spexin in the rat and human carotid body. Moreover, the carotid body is known to undergo various structural and functional modifications in response to hyperoxic stimuli during the first postnatal period. Thus, we also evaluated if hyperoxia during the first postnatal weeks may produce changes in the spexin expression. Materials consisted of carotid bodies obtained at autopsy from five human adult subjects and sampled from 10 six-weeks old Sprague–Dawley rats. Five rats were maintained in normoxia for the first six postnatal weeks; five rats were exposed to 60% hyperoxia for 2 weeks and then maintained in normoxia for other 4 weeks. Diffuse anti-spexin immunoreactivity was found in type I cells of both humans and rats. No spexin immunoreactivity was visible in the type II cells. Hyperoxia exposure during the first 2 weeks of postnatal life caused a reduction of volume in the carotid body still apparent after 4 weeks of normoxia. Using real-time PCR, spexin expression was 6–7 times higher in hyperoxia-exposed rats than in normoxia-exposed ones. The expression of spexin in type I cells suggests a possible modulator role in peripheral chemoreception. Moreover, the ascertained role of spexin in the regulation of cell proliferation in other tissues (e.g., adrenal gland cortex) suggests a possible role of spexin also in the hyperoxia-induced plasticity of the carotid body.